((S)-3-Methyl-5,6,7,8-tetrahydro-indolizin-7-yl)-dipropyl-amine

ID: ALA96958

PubChem CID: 44329314

Max Phase: Preclinical

Molecular Formula: C15H26N2

Molecular Weight: 234.39

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCCN(CCC)[C@H]1CCn2c(C)ccc2C1

Standard InChI:  InChI=1S/C15H26N2/c1-4-9-16(10-5-2)14-8-11-17-13(3)6-7-15(17)12-14/h6-7,14H,4-5,8-12H2,1-3H3/t14-/m0/s1

Standard InChI Key:  OAWCCPORHBJQQY-AWEZNQCLSA-N

Molfile:  

     RDKit          2D

 17 18  0  0  1  0  0  0  0  0999 V2000
    9.8792   -2.5500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.5917   -2.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0542   -3.3542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5917   -1.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2167   -2.7000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8792   -3.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1667   -2.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8792   -0.9000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1667   -1.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8792   -0.0750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.5042   -3.9667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1667    0.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5917    0.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5917    1.1625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1667    1.1625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3125    1.5750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4542    1.5750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  2  1  0
  5  2  2  0
  6  3  2  0
  7  1  1  0
  8  9  1  0
  9  7  1  0
  8 10  1  6
 11  3  1  0
 12 10  1  0
 13 10  1  0
 14 13  1  0
 15 12  1  0
 16 14  1  0
 17 15  1  0
  5  6  1  0
  4  8  1  0
M  END

Associated Targets(Human)

DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

DRD1 Dopamine D1 receptor (387 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Dopamine D2 receptor (774 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 234.39Molecular Weight (Monoisotopic): 234.2096AlogP: 3.23#Rotatable Bonds: 5
Polar Surface Area: 8.17Molecular Species: BASEHBA: 2HBD:
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.58CX LogP: 3.10CX LogD: 0.09
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.76Np Likeness Score: -1.13

References

1. Lehmann T, Hübner H, Gmeiner P..  (2001)  Dopaminergic 7-aminotetrahydroindolizines: ex-chiral pool synthesis and preferential D3 receptor binding.,  11  (21): [PMID:11597417] [10.1016/s0960-894x(01)00564-9]
2. Boeckler F, Ohnmacht U, Lehmann T, Utz W, Hübner H, Gmeiner P..  (2005)  CoMFA and CoMSIA investigations revealing novel insights into the binding modes of dopamine D3 receptor agonists.,  48  (7): [PMID:15801839] [10.1021/jm049269+]

Source